HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yashar, J. Articles by Wanebo, H. J. Search for Related Content PubMed PubMed Citation Articles by Yashar, J. Articles by Wanebo, H. J.

The Annals of Thoracic Surgery, Vol 53, 445-448, Copyright © 1992 by The Society of Thoracic Surgeons

ARTICLES

Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lung

J Yashar, AB Weitberg, AS Glicksman, MR Posner, W Feng and HJ Wanebo
Division of Thoracic Surgery, Roger Williams Cancer Center, Providence, RI 02908.

Thirty-six patients with stage IIIa histologically proven non-small cell carcinoma (T3 N2 or T2 N2) underwent concomitant radiation therapy and chemotherapy before pulmonary resection. The therapy consisted of two cycles of continuous infusion of cis-platinum, 25 mg.m-2.day-1 (days 1 through 4) every 4 weeks and concomitant irradiation, 55 Gy, of the tumor and mediastinum. Two to 3 weeks after treatment, the patients were reevaluated for thoracotomy and pulmonary resection. Five patients were found to have unresectable lesions. Thirty-one patients had complete resection, 27 by radical pneumonectomy and 4 by radical lobectomy, giving a resectability rate of 86%. Complete sterilization of lung tumor and mediastinal nodes proven histologically was achieved in 10 patients (28%) and 17 patients (47%). The 3-year survival rate is 61.7% for patients who had resection. Median follow-up is 27 months (range, 6 to 61 months). The preliminary study indicates that preoperative cis-platinum and concomitant radiation therapy is tolerated, appears to increase resectability, and may improve survival in patients with stage IIIa lung cancer.

This article has been cited by other articles:

				S. Gursoy, M. U Yapucu, A. Ucvet, S. Yazgan, O. Basok, and S. Ermete Fibrin Glue Administration to Support Bronchial Stump Line Asian Cardiovasc Thorac Ann, December 1, 2008; 16(6): 450 - 453. [Abstract] [Full Text] [PDF]

				B. D.T. Daly, H. C. Fernando, A. Ketchedjian, T. A. DiPetrillo, L. A. Kachnic, D. M. Morelli, and R. J. Shemin Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. Ann. Thorac. Surg., July 1, 2006; 82(1): 227 - 231. [Abstract] [Full Text] [PDF]

				B. F. Meyers, F. Haddad, B. A. Siegel, J. B. Zoole, R. J. Battafarano, N. Veeramachaneni, J. D. Cooper, and G. A. Patterson Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 822 - 829. [Abstract] [Full Text] [PDF]

				M. Goldberg, D. Gupta, A. R. Sasson, B. Movsas, C. J. Langer, A. L. Hanlon, H. Wang, and W. J. Scott The Surgical Management of Superior Sulcus Tumors: A Retrospective Review With Long-Term Follow-Up Ann. Thorac. Surg., April 1, 2005; 79(4): 1174 - 1179. [Abstract] [Full Text] [PDF]

				M. K. Ferguson Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1935 - 1942. [Abstract] [Full Text] [PDF]

				K. L. Greason, D. L. Miller, R. P. Clay, C. Deschamps, C. H. Johnson, M. S. Allen, V. F. Trastek, and P. C. Pairolero Management of the irradiated bronchus after lobectomy for lung cancer Ann. Thorac. Surg., July 1, 2003; 76(1): 180 - 185. [Abstract] [Full Text] [PDF]

				S. Margaritora, A. Cesario, D. Galetta, A. D'Andrilli, G. Macis, G. Mantini, L. Trodella, and P. Granone Ten year experience with induction therapy in locally advanced non-small cell lung cancer (NSCLC): is clinical re-staging predictive of pathological staging? Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 894 - 898. [Abstract] [Full Text] [PDF]

				M. P. Siegenthaler, K. M. Pisters, K. W. Merriman, J. A. Roth, S. G. Swisher, G. L. Walsh, A. A. Vaporciyan, W. R. Smythe, and J. B. Putnam Jr Preoperative chemotherapy for lung cancer does not increase surgical morbidity Ann. Thorac. Surg., April 1, 2001; 71(4): 1105 - 1112. [Abstract] [Full Text] [PDF]

				J. R. Sonett, M. J. Krasna, M. Suntharalingam, J. Schuetz, L. A. Doyle, R. Lilenbaum, and Z. Gamliel Safe pulmonary resection after chemotherapy and high-dose thoracic radiation Ann. Thorac. Surg., August 1, 1999; 68(2): 316 - 320. [Abstract] [Full Text] [PDF]

				M. P. Hagan, N. C. Choi, D. J. Mathisen, J. C. Wain, C. D. Wright, and H. C. Grillo SUPERIOR SULCUS LUNG TUMORS: IMPACT OF LOCAL CONTROL ON SURVIVAL J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1086 - 1094. [Abstract] [Full Text] [PDF]